Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty

PHASE3CompletedINTERVENTIONAL

Enrollment

407

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions

Acute Pain

Interventions

DRUG

Oliceridine

DRUG

Placebo

DRUG

Morphine

Trial Locations (5)

Research Site, Pasadena

Research Site, Houston

Research Site, San Antonio

Research Site, Phoenix

Research Site, Pasadena

All Listed Sponsors

lead

Trevena Inc.

INDUSTRY

NCT02820324 - Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty | Biotech Hunter | Biotech Hunter